bell
The current prices are delayed by 15 mins, login to check live prices.
Rossari Biotech Ltd share price logo

Rossari Biotech Ltd

(ROSSARI)

₹822.80.65%

as on 04:01PM, 02 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Rossari Biotech Ltd Analyst Rating

based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts offering long term price targets for Rossari Biotech Ltd. An average target of ₹988.25

Source: S&P Global Market Intelligence

Rossari Biotech Ltd Share analysis

Rossari Biotech Ltd price forecast by 4 analysts

Upside of20.89%

High

₹1085

Target

₹988.25

Low

₹830

Rossari Biotech Ltd target price ₹988.25, a slight upside of 20.89% compared to current price of ₹822.8. According to 4 analysts rating.

Source: S&P Global Market Intelligence

Rossari Biotech Ltd Performance

  • Day's Low

    Day's High

    ₹815
    ₹829.1
  • 52 Week's Low

    52 Week's High

    ₹656.95
    ₹972.7
1 Month Return+ 2.48 %
3 Month Return-8.69 %
1 Year Return+ 5.94 %
Previous Close₹817.45
Open₹820.00
Volume35.02K
Upper Circuit-
Lower Circuit-
Market Cap₹4,519.62Cr

Rossari Biotech Ltd Key Statistics

P/E Ratio32.54
PEG Ratio8.26
Market Cap₹4,519.62 Cr
P/B Ratio3.88
EPS23.66
Dividend Yield0
SectorChemicals
ROE10.96

Rossari Biotech Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹4,519.62 Cr2.04%0.53₹130 Cr₹1,830 Cr
NA₹9,386.57 Cr47.49%0.56₹484 Cr₹7,929 Cr
BUY₹16,376.22 Cr120.18%0.74₹491 Cr₹6,419 Cr
HOLD₹7,455.31 Cr90.7%0.75₹95 Cr₹1,752 Cr
SELL₹6,466.09 Cr15.94%0.54₹164 Cr₹2,603 Cr

About Rossari Biotech Ltd

Rossari Biotech Limited, founded in 2003 as a partnership firm, is engaged in the manufacture, sale and distribution of specialty chemicals. It has two state-of-the-art facilities in Dahej in Gujarat and Silvassa in Dadra Nagar Haveli. It caters to global FMCG brands and its applications are used in consumer and home care products, textiles, animal health and nutrition and cosmetics. In FY 2020, the Company subdivided 5 million equity shares to 25 million equity shares and allotted 2.6 million equity shares to eligible members of the Company. It also issued 2.35 million equity shares to qualified institutional buyers on a preferential basis. During Q2 FY2021, IPOs of 11.7 million equity shares were issued with 10.5 million allotted to selling shareholders and 1.17 million to the fresh issue at a premium of Rs.423. During FY 2021, 3012046 equity shares were issued to the eligible members on a preferential basis whileUnitop Chemicals Private Limited, Tristar Intermediates Private Limited and Romakk Chemicals Private Limited were acquired by the Company. Solar panel was installed at Dahej facility to accommodate 1 MW solar power installation in FY 2022 which helped to save energy by 50 KVA. During 202122 several product developments have been made for the sizing of polyester and cotton fabric and the development of green products to reduce high TDS. Significant cross-selling opportunities have also been unlocked with the strategic investments made.

Share Price: ₹822.80 per share as on 02 Dec, 2024 04:01 PM
Market Capitalisation: ₹4,519.62Cr as of today
Revenue: ₹498.35Cr as on September 2024 (Q3 24)
Net Profit: ₹35.33Cr as on September 2024 (Q3 24)
Listing date: 23 Jul, 2020
Chairperson Name: Edward Menezes
OrganisationRossari Biotech Ltd
HeadquartersMumbai
IndustryChemicals
E-voting on sharesClick here to vote

Key events for Rossari Biotech Ltd

  • KR Choksey Maintains Buy Rating on Rossari Biotech - 23 Oct, 2024

    Despite lower-than-expected Q2FY25 results, KR Choksey maintains a BUY rating on Rossari Biotech with a target price of Rs 1,034, citing long-term growth potential and strong export opportunities.
  • Rossari Biotech Faces Downgrade Amid Demand Concerns - 22 Oct, 2024

    ICICI Securities has downgraded Rossari Biotech to HOLD, reducing the target price to Rs 830 due to weaker demand and lower EPS estimates. In contrast, Anand Rathi maintains a positive outlook with a target of Rs 1,085, citing growth potential from capacity expansion and product launches.
  • Rossari Biotech Stock Declines After Q2 Earnings - 21 Oct, 2024

    Following the release of Q2 FY24-25 earnings, Rossari Biotech's stock fell 4.28% due to disappointing results and concerns over growth and profitability pressures.
  • Rossari Biotech Reports Q2 Profit Growth - 20 Oct, 2024

    Rossari Biotech reported a 7.3% YoY increase in net profit to ₹35.3 crore for Q2 FY2024, with revenue rising 1.8% to ₹498.3 crore.
  • Rossari Biotech Reports Q2 Earnings Growth - 19 Oct, 2024

    Rossari Biotech Ltd announced a 7% increase in net profit to ₹35 crore and a 2% rise in revenue to ₹498 crore for Q2 FY2024. The company also appointed Gurudas Aras as a Non-Executive Independent Director and reappointed Aseem Dhru for a second term. Shares closed down 0.48% on October 18.

Insights on Rossari Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 12.96% to 13.18% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 467.29 Cr → 499.36 Cr (in ₹), with an average increase of 2.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 34.13 Cr → 35.33 Cr (in ₹), with an average increase of 1.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, PCBL Ltd has given 276.7% return, outperforming this stock by 313.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, PCBL Ltd has given 58.1% return, outperforming this stock by 52.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, ROSSARI stock has moved down by -36.7%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 3.83% to 3.74% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 68.32% to 68.27% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 10.98% to 10.65% in Sep 2024 quarter

Rossari Biotech Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹483.47Cr (-)₹463.77Cr (↓4.07%)₹472.72Cr (↑1.93%)₹489.65Cr (↑3.58%)₹498.35Cr (↑1.78%)
Net Income₹32.95Cr (-)₹34.39Cr (↑4.37%)₹34.13Cr (↓0.76%)₹34.90Cr (↑2.26%)₹35.33Cr (↑1.23%)
Net Profit Margin6.82% (-)7.42% (↑8.80%)7.22% (↓2.70%)7.13% (↓1.25%)7.09% (↓0.56%)
Value in ₹ crore
Details2021202220232024
Total Assets₹544.36Cr (-)₹925.94Cr (↑70.10%)₹1,125.67Cr (↑21.57%)₹1,281.17Cr (↑13.81%)
Total Liabilities₹139.91Cr (-)₹141.42Cr (↑1.08%)₹266.97Cr (↑88.78%)₹320.83Cr (↑20.17%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹55.75Cr (-)₹52.09Cr (↓6.57%)₹33.12Cr (↓36.42%)₹112.94Cr (↑241.00%)₹73.92Cr (↓34.55%)

Index Inclusions

S&P BSE Commodities

₹7,516.53

1.59 (117.72%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹55,662.71

0.84 (462.85%)

Rossari Biotech Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
68.27%
-0.08
Foreign Institutions
3.74%
-2.33
Mutual Funds
13.18%
1.73
Retail Investors
10.65%
-2.96
Others
4.15%
6.17

Rossari Biotech Ltd Key Indicators

Details20202021202220232024
Return On Equity %32.452313.378.6910.96
Details20202021202220232024
Return On Assets %13.9314.7410.559.5310.2
Details2021202220232024
Book Value Per Share (₹)78.72146.25165.93189.65
Details2021202220232024
Earning Per Share (₹)15.4117.7419.4523.66

Rossari Biotech Ltd Valuation

Rossari Biotech Ltd in the last 5 years

  • Overview

  • Trends

Lowest (28.32x)

June 4, 2024

Today (32.54x)

November 29, 2024

Industry (58.93x)

November 29, 2024

Highest (90.67x)

September 15, 2021

LowHigh

Rossari Biotech Ltd Earnings and Dividends

  • Rossari Biotech Ltd Earnings Results

    Rossari Biotech Ltd’s net profit jumped 7.22% since last year same period to ₹35.33Cr in the Q2 2024-2025. On a quarterly growth basis, Rossari Biotech Ltd has generated 1.23% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Rossari Biotech Ltd Dividends April,2024

    In the quarter ending March 2024, Rossari Biotech Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.12%.

    Read More about Dividends

Rossari Biotech Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Rossari Biotech Ltd is currently in a Bullish trading position according to technical analysis indicators.

FAQs on Rossari Biotech Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Rossari Biotech Ltd shares.

Rossari Biotech Ltd (ROSSARI) share price today is ₹822.8

Rossari Biotech Ltd is listed on NSE

Rossari Biotech Ltd is listed on BSE

  • Today’s highest price of Rossari Biotech Ltd is ₹829.1.
  • Today’s lowest price of Rossari Biotech Ltd is ₹815.

PE Ratio of Rossari Biotech Ltd is 32.54

PE ratio = Rossari Biotech Ltd Market price per share / Rossari Biotech Ltd Earnings per share

Today’s traded volume of Rossari Biotech Ltd(ROSSARI) is 35.02K.

Today’s market capitalisation of Rossari Biotech Ltd(ROSSARI) is ₹4519.62Cr.

Rossari Biotech Ltd(ROSSARIPrice
52 Week High
₹972.7
52 Week Low
₹656.95

Rossari Biotech Ltd(ROSSARI) share price is ₹822.8. It is down -15.41% from its 52 Week High price of ₹972.7

Rossari Biotech Ltd(ROSSARI) share price is ₹822.8. It is up 25.25% from its 52 Week Low price of ₹656.95

Rossari Biotech Ltd(ROSSARIReturns
1 Day Returns
5.35%
1 Month Returns
2.48%
3 Month Returns
-8.69%
1 Year Returns
5.94%